Arşiv logosu
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
Arşiv logosu
  • Koleksiyonlar
  • Sistem İçeriği
  • Analiz
  • Talep/Soru
  • Türkçe
  • English
  • Giriş
    Yeni kullanıcı mısınız? Kayıt için tıklayın. Şifrenizi mi unuttunuz?
  1. Ana Sayfa
  2. Yazara Göre Listele

Yazar "Derekoy, F. S." seçeneğine göre listele

Listeleniyor 1 - 2 / 2
Sayfa Başına Sonuç
Sıralama seçenekleri
  • [ X ]
    Öğe
    Does topical use of autologous serum help to reduce post-tonsillectomy morbidity? A prospective, controlled preliminary study
    (Cambridge Univ Press, 2016) Kara, M.; Erdogan, H.; Altinisik, H. B.; Aylanc, H.; Guclu, O.; Derekoy, F. S.
    Background: To evaluate the effects of autologous serum usage on throat pain, haemorrhage and tonsillar fossa epithelisation in patients after tonsillectomy. Methods: Thirty-two patients (aged 4-15 years) were included in the study. Tonsillectomy was performed and autologous serum was administered topically to the right tonsillar fossa during the operation, and at 8 and 24 hours post-operatively. The left side served as the control. A visual analogue scale was used to record the patient's pain every day. Each patient's oropharynx was observed on the 5th and 10th post-operative days to examine bleeding and epithelisation. Results: The pain scores for the side administered autologous serum were significantly lower than those for the control side, on the night following the operation and on the 1st, 2nd, 5th and 6th post-operative days. Tonsillar fossa epithelisation was significantly accelerated on the study side compared with the control side on the 5th and 10th post-operative days. Conclusion: In tonsillectomy patients, topically administered autologous serum contributed to throat pain relief and tonsillar fossa epithelisation during the post-operative period.
  • [ X ]
    Öğe
    Effects of nonsteroidal anti-inflammatory drugs on hearing
    (Galenos Yayincilik, 2012) Guclu, O.; Sargin, R.; Duman, K.; Aycicek, A.; Derekoy, F. S.; Kavuncu, V.
    Objectives: Non steroidal anti-inflammatory drugs (NSAID) use with high dose and long time for chronic inflammation. It was well known that these drugs have ototoxic effects. The more study about ototoxic effects of acetyl salicylic acid (ASA) and quinine has been at the literature. In this study, the effects to hearing of NSAID except ASA and quinine were evaluated. Methods: Twenty-three patients with started chronic medication for the pathology of muscle-skeleton system were included the study. Pure tone audiometry and otoacoustic emissions were made in the beginning and a month after using dugs. Results: Audiometric findings were compared by considering frequency scale and the hearing loss over 10 dB was accepted significant. At the low frequencies (250, 500, 1000 Hz) were not observed any statistically significant change (p>0.05). There was a significant hearing loss at 12 ear (26%) in 8 kHz, 9 ear (19.5%) in 4 kHz, 6 ear (13%) in 2 kHz (p<0.05). Conclusion: After using the medication emissions of only two ears were lost. NSAID like diclofenac potasium, etadolac, meloxicam ve diflunisal have ototoxic effects and especially high frequencies are affected. In our opinion if clinicians prefer NSAID especially for long term and high dose, they must be careful for ototoxicity.

| Çanakkale Onsekiz Mart Üniversitesi | Kütüphane | Açık Erişim Politikası | Rehber | OAI-PMH |

Bu site Creative Commons Alıntı-Gayri Ticari-Türetilemez 4.0 Uluslararası Lisansı ile korunmaktadır.


Çanakkale Onsekiz Mart Üniversitesi, Çanakkale, TÜRKİYE
İçerikte herhangi bir hata görürseniz lütfen bize bildirin

DSpace 7.6.1, Powered by İdeal DSpace

DSpace yazılımı telif hakkı © 2002-2025 LYRASIS

  • Çerez Ayarları
  • Gizlilik Politikası
  • Son Kullanıcı Sözleşmesi
  • Geri Bildirim